课题基金 / 基金详情

COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2

COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
COVID 补充:一项多中心研究,旨在研究感染 SARS-CoV-2 后产生的免疫反应
批准号:
10621133
负责人:
TED ROSS
金额:
$6.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2023-05-14

项目摘要

项目成果

TED ROSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Georgia University Research Foundation to support the National Cancer Institute's multi-site study seeking to evaluate antibody responses to SARS-CoV-2 virus in high risk populations including health workers, first responders, frontline worker (e.g. grocery store employees) and disproportionately affected minorities. The goal of the study is to determine the durability of antibody titers following COVID infection and to identify correlates of antibody-mediated protection from re-infection in COVID survivors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10242598
  • 项目类别:
  • 资助金额:
    $1074.98万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10021763
  • 项目类别:
  • 资助金额:
    $800.0万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10788197
  • 项目类别:
  • 资助金额:
    $1070.0万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
  • 批准号:
    10621131
  • 项目类别:
  • 资助金额:
    $1018.84万
  • 财政年份:
    2019
  • 负责人:
    TED ROSS
  • 依托单位:
海外基金